This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Asahi Pharma Corporation, National Cancer Center. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 263 
Years Active: 2014
Title: Ryou-u Takahashi: Innovator in Cancer Therapeutics
Introduction
Ryou-u Takahashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in developing therapeutic agents for drug-resistant tumors. His innovative work aims to improve treatment options for patients facing challenging cancer diagnoses.
Latest Patents
Takahashi holds a patent for a therapeutic agent for tumors. This invention specifically addresses drug-resistant cancer and aims to suppress or prevent tumor metastasis and recurrence. The therapeutic agent contains a nucleic acid that includes miR27b or a nucleotide sequence with a high degree of identity to the sequence shown by SEQ ID NO: 1, which functions similarly to miR27b.
Career Highlights
Throughout his career, Ryou-u Takahashi has worked with esteemed organizations such as the National Cancer Center and Asahi Pharma Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapeutics.
Collaborations
One of his notable collaborators is Takahiro Ochiya, with whom he has worked on various projects aimed at advancing cancer treatment methodologies.
Conclusion
Ryou-u Takahashi's innovative contributions to cancer therapeutics highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile